Changes in butyrylcholinesterase activity in patients with Alzheimer disease treated with acetylcholinesterase inhibitors

被引：0
|
作者：
Sanchez Morillo, J. [1 ]
Estruch Perez, M. J. [1 ]
Barber Ballester, G. [1 ]
Pertusa Collado, V. [1 ]
机构：
[1] Hosp Univ Dr Peset, Serv Anestesiol & Reanimac, Valencia, Spain
来源：
NEUROLOGIA | 2011年 / 26卷 / 04期
关键词：
SUXAMETHONIUM; EDROPHONIUM; NEOSTIGMINE; THERAPY;
D O I：
10.1016/j.nrl.2010.09.025
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：247 / 248
页数：2
相关论文
共 50 条
  • [41] Development of acetylcholinesterase inhibitors in the therapy of Alzheimer's disease
    Taylor, P
    NEUROLOGY, 1998, 51 (01) : S30 - S35
  • [42] Old and new acetylcholinesterase inhibitors for Alzheimer's disease
    Galimberti, Daniela
    Scarpini, Elio
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2016, 25 (10) : 1181 - 1187
  • [43] A review on coumarins as acetylcholinesterase inhibitors for Alzheimer's disease
    Anand, Preet
    Singh, Baldev
    Singh, Nirmal
    BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (03) : 1175 - 1180
  • [44] Progress in acetylcholinesterase inhibitors for Alzheimer's disease: an update
    Tumiattit, Vincenzo
    Bolognesi, Maria Laura
    Minarini, Anna
    Rosini, Michela
    Milelli, Andrea
    Matera, Riccardo
    Melchiorre, Carlo
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2008, 18 (04) : 387 - 401
  • [45] BLOOD ACETYLCHOLINESTERASE AND BUTYRYLCHOLINESTERASE IN SENILE DEMENTIA OF ALZHEIMER TYPE
    ATACK, JR
    PERRY, EK
    PERRY, RH
    WILSON, ID
    BOBER, MJ
    BLESSED, G
    TOMLINSON, BE
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1985, 70 (01) : 1 - 12
  • [46] Acetylcholinesterase inhibitors and nanoparticles on Alzheimer’s disease: a review
    Sara Silva
    António J. Almeida
    Nuno Vale
    Journal of Nanoparticle Research, 2021, 23
  • [47] Target Enzyme in Alzheimer's Disease: Acetylcholinesterase Inhibitors
    Saxena, Mridula
    Dubey, Ragini
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2019, 19 (04) : 264 - 275
  • [48] Pharmacophore mapping of the crucial mediators of acetylcholinesterase and butyrylcholinesterase dual inhibition in Alzheimer's disease
    Fatima Y. Adeowo
    Ahmed A. Elrashedy
    Murtala A. Ejalonibu
    Isiaka A. Lawal
    Monsurat M. Lawal
    Hezekiel M. Kumalo
    Molecular Diversity, 2022, 26 : 2761 - 2774
  • [49] Pharmacophore mapping of the crucial mediators of acetylcholinesterase and butyrylcholinesterase dual inhibition in Alzheimer's disease
    Adeowo, Fatima Y.
    Elrashedy, Ahmed A.
    Ejalonibu, Murtala A.
    Lawal, Isiaka A.
    Lawal, Monsurat M.
    Kumalo, Hezekiel M.
    MOLECULAR DIVERSITY, 2022, 26 (05) : 2761 - 2774
  • [50] Anticholinergic burden in patients treated with acetylcholinesterase inhibitors
    Ruiz Fuentes, Salvador
    Caparros Romero, Salud
    Valverde Alcala, Eva
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2021, 43 (06) : 1781 - 1781
12345